We launched a survey in 2020 to find out your views on how the UK National Screening Committee (UK NSC) involves stakeholders and the public in its work.
UK National Screening Committee
The NHS severe combined immunodeficiency (SCID) screening evaluation in England is scheduled to start from September 2021.
It's hard to believe it's been a year since the last annual call, but the UK National Screening Committee (UK NSC) is once again open to ideas for new population screening programmes.
In 2019, around 130 delegates attended the first national PHE Screening Inequalities Conference.
Find out about the second edition of the Screening: Evidence and Practice book by Angela Raffle, Anne Mackie and Muir Gray.
An opportunity to propose a new health screening programme.
The UK National Screening Committee evidence team is trialling a new approach to make the process of reviewing evidence for screening more efficient.
The screening masterclass is still going strong nearly 20 years on.
New guidance coming about how artificial intelligence (AI) could be used for screening.
Professor Anne Mackie explains that it is important that healthcare policy makers do not risk undermining or overlapping with NHS population screening.